Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Triple Negative Breast Neoplasms

1,2-dipalmitoylphosphatidylcholine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doolittle, E; Doron, G; Goldberg, A; Govender, P; Karathanasis, E; Lee, Z; Peiris, PM; Rao, S; Schiemann, WP; Shah, S; Sylvestre, M; Tucci, S; Turan, O1

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Triple Negative Breast Neoplasms

ArticleYear
Spatiotemporal Targeting of a Dual-Ligand Nanoparticle to Cancer Metastasis.
    ACS nano, 2015, Aug-25, Volume: 9, Issue:8

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Cell Line, Tumor; Cholesterol; Diagnostic Imaging; Drug Compounding; Drug Delivery Systems; Female; Gene Expression; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasm Transplantation; P-Selectin; Protein Binding; Recombinant Proteins; Triple Negative Breast Neoplasms

2015